View in EDS

Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study

Saved in:

Bibliographic Details
Title:	Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study
Authors:	Fotia, Giuseppe¹, Saieva, Calogero², Lee-Ying, Richard³, Patrikidou, Anna⁴, Nuzzo, Pier Vitale⁵, Zanardi, Elisa⁶, Rossetti, Sabrina⁷, Davidsohn, Matthew⁸, Eid, Marc⁸, El Zarif, Talal⁸, McClure, Heather⁸, Spinelli, Gian Paolo⁹, Damassi, Alessandra⁶, Murianni, Veronica⁶, Vauchier, Charles⁴, Oliveira, Thiago Martins¹⁰, Malgeri, Andrea¹¹, Modesti, Mikol¹², Mestre, Ricardo Pereira¹², Valenca, Loana¹⁰
Source:	Clinical Genitourinary Cancer. Oct2024, Vol. 22 Issue 5, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	15587673
DOI:	10.1016/j.clgc.2024.102185